Enoxar Contraindications

2000 IU/0.2 mL and 6000 IU/0.6 mL soln for inj: Enoxaparin is contraindicated in patients with active major bleeding, in patients with thrombocytopenia associated with a positive in vitro test for antiplatelet antibody in the presence of Enoxaparin Sodium, or in patients with hypersensitivity to Enoxaparin Sodium. Patients with known hypersensitivity.
4000 IU/0.4 mL soln for inj: Enoxaparin sodium is contraindicated in patients with: Hypersensitivity to enoxaparin sodium, heparin or its derivatives, including other low molecular weight heparins (LMWH) or to any of the excipients present in the formulation.
History of immune-mediated heparin-induced thrombocytopenia (HIT) within the past 100 days or in the presence of circulating antibodies.
Active clinically significant bleeding and conditions with a high risk of hemorrhage, including recent hemorrhagic stroke, gastrointestinal ulcer, presence of malignant neoplasm at high risk of bleeding, recent brain, spinal or ophthalmic surgery, known or suspected esophageal varices, arteriovenous malformations, vascular aneurysms or major intra spinal or intracerebral vascular abnormalities.
Spinal or epidural anesthesia or loco-regional anesthesia when enoxaparin sodium is used for treatment in the previous 24 hours.